What does foreign exchange and other gains, net mean?

The net impact of fluctuations in foreign exchange rates on the company's assets, liabilities, and transactions denominated in non-functional currencies. This metric captures the volatility inherent in international operations or cross-border financial activities. It is used to assess the effectiveness of the company's currency risk management strategies.

King Pharmaceuticals KG Foreign exchange and other gains, net

Foreign exchange and other gains, net at other companies

Babcock & Wilcox EnterprisesBW

-$101K+74.9%

Silvaco Group, Inc.SVCO

-$50K+50.0%

Bausch Health CompaniesBHC

-$5M-350%

HTF

Heartflow, Inc. Common StockHTFL

-$418K-17.1%

Forum Energy TechnologiesFET

$156.75K—

Rayonier Advanced MaterialsRYAM

$1.07M+196%

Other financials

Income statement

See full

Revenue$10.2M+1,112%

Net income-$7.4M-1,786%

EPS (diluted)-$0.96-586%

Balance sheet

See full

Cash & equivalents$62.2M+1,724%

Total debt$176.7M—

Total equity$121.4M+2,773%

Total assets$964.2M—

Cash flow

See full

Operating cash flow-$15.1M-1,628%

Valuation

See full

Market cap$70.42M-71.3%

Enterprise value$184.93M-52.3%

P/E1.2×—

P/S1.6×-27.7×

Profitability

See full

Net margin131.5%—

Returns & leverage

See full

Return on equity90.8%—

Debt / equity1.5×—

Where this comes from

Reported directly by King Pharmaceuticals in its filing.

Tagged under the XBRL concept kg:ForeignCurrencyTransactionandOtherGainLossbeforeTax.

The official record: King Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about King Pharmaceuticals's foreign exchange and other gains, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is King Pharmaceuticals's foreign exchange and other gains, net?: King Pharmaceuticals (KG) reported foreign exchange and other gains, net of $2.23M in Q1 2026.
What does foreign exchange and other gains, net mean?: The net impact of fluctuations in foreign exchange rates on the company's assets, liabilities, and transactions denominated in non-functional currencies. This metric captures the volatility inherent in international operations or cross-border financial activities. It is used to assess the effectiveness of the company's currency risk management strategies.